- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01465360
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup-A Pilot Descriptive Study
Studieöversikt
Status
Detaljerad beskrivning
The objective of this study is to apply AclarusDx™ signature in a reference US Center in 160 patients newly referred to one of the three study centers within the Cleveland Clinic, Center for Brain Health network, for diagnostic workup. Only AclarusDx™ will be added to the panel of tests usually performed at the centers to establish diagnosis. AclarusDx™ will be used for investigational use only, not for diagnostic purpose. The ultimate goal is to define the clinical utility of AclarusDx™ to provide Primary Care Physicians (PCPs) with a tool that will help them in making the diagnosis of Alzheimer's Disease (AD).
The primary objectives are :
- To obtain an estimate of the capability of AclarusDx™ to identify AD patients among a US-based population of newly referred patients suffering from objective memory impairment which maybe potentially related to multiple and different etiologies.
- To compare the performance of AclarusDx™ in a US-based population of newly referred patients with memory impairment with the performance of AclarusDx™ observed in one comparable European population.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Nevada
-
Las Vegas, Nevada, Förenta staterna, 89106
- Cleveland Clinic Lou Ruvo Center for Brain Health
-
-
Ohio
-
Cleveland, Ohio, Förenta staterna, 44195
- Cleveland Clinic Center for Brain Health - Mellen Center
-
Lakewood, Ohio, Förenta staterna, 44107
- Cleveland Clinic Senior Care Assessment - Lakewood Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Male or female patient referred to the center for memory impairment.
- The memory impairment has previously been observed by a caregiver or documented by a physician.
- The memory impairment is confirmed by the memory center.
- Caucasian ethnicity.
- A written informed consent approved by an ethical review board or similar body must be obtained from the patient prior to any study-related procedures.
- If applicable, standard treatment with cholinesterase inhibitor and/or memantine is acceptable.
- Patient estimated to be compliant with study procedures.
- Patient has a level of understanding sufficient to agree to all procedures required by the protocol and must be able to cooperate. Under no circumstances will a subject who does not understand the procedure, be allowed to consent to the procedure.
Exclusion Criteria:
- Recent acute pathology or medical condition or surgery which may alter the inflammatory homeostasis, according to the opinion of the investigator.
- Non-Caucasian ethnicity.
- Patient with severe uncontrolled or unstable medical condition.
- Need for a legal representative for the medical condition of the patient.
- Any current pathology or medical condition, for which blood sampling may involve a risk for the patient's health, according to the opinion of the investigator.
- Current or recent history (within one month) of clinically significant pathology, medical condition (including hospitalization) or symptoms. However, chronic diseases or medical conditions that are considered stable are accepted, provided that they are compatible with other study selection criteria.
- Current or recent history of drug or alcohol abuse or dependence.
- Current, clinically significant major psychiatric disorder (eg, major depressive disorder) according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition text revised (DSM-IV TR), or significant symptoms (eg, hallucinations).
- Woman of childbearing potential is not allowed to participate in the study. (A woman of childbearing potential is a woman who is biologically capable of becoming pregnant).
- Current participation in another study using an investigational non-marketed product.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
Study patients
Patients newly referred to a Reference Memory Center with a complaint of memory impairment for AD diagnostic workup.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Sensitivity of AclarusDx™ in AD patients
Tidsram: Outcome measured during one single study visit
|
The determination of the sensitivity of the test, being the percentage of positive AclarusDx™ calls among referred patients being confirmed clinically as having AD at the Memory Center will be calculated.
|
Outcome measured during one single study visit
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Charles B. Bernick, MD, Cleveland Clinic Lou Ruvo Center for Brain Health
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Mentala störningar
- Hjärt-kärlsjukdomar
- Kärlsjukdomar
- Metaboliska sjukdomar
- Cerebrovaskulära störningar
- Hjärnsjukdomar
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Arterioskleros
- Arteriella ocklusiva sjukdomar
- Neurologiska manifestationer
- Neurobehavioral manifestationer
- Neurokognitiva störningar
- Parkinsons sjukdom
- Basala ganglia sjukdomar
- Rörelsestörningar
- Synukleinopatier
- Neurodegenerativa sjukdomar
- TDP-43 Proteinopatier
- Proteostasbrister
- Tauopatier
- Kognitionsstörningar
- Språkstörningar
- Kommunikationsstörningar
- Intrakraniella arteriella sjukdomar
- Talstörningar
- Frontotemporal Lobar Degeneration
- Intrakraniell arterioskleros
- Leukoencefalopati
- Parkinsons sjukdom
- Demens
- Alzheimers sjukdom
- Kognitiv dysfunktion
- Afasi
- Frontotemporal demens
- Afasi, Primär progressiv
- Pick sjukdom i hjärnan
- Demens, Vaskulär
Andra studie-ID-nummer
- EHTAD/003
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Lätt kognitiv funktionsnedsättning
-
University of Texas Southwestern Medical CenterTEXAS ALZHEIMER'S RESEARCH & CARE CONSORTIUMRekryteringDemens | Lätt kognitiv funktionsnedsättning | Amnestic Mild Cognitive Impairment - aMCIFörenta staterna
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RekryteringSömnstörning | AMCI - Amnestic Mild Cognitive ImpairmentFörenta staterna
-
Dart NeuroScience, LLCAvslutadAge-Associated Memory Impairment (AAMI)Förenta staterna
-
Invendo Medical GmbHAvslutad
-
St. Boniface HospitalPizzey Ingredients; Canadian Agricultural PartnershipAktiv, inte rekryterandeMinne; Störning, mildKanada
-
Mayo ClinicRekryteringAutonom kortisolutsöndring | Mild autonom kortisolsekretion (MACS)Förenta staterna
-
Chonbuk National University HospitalAvslutadMild leverskadaKorea, Republiken av
-
Solta MedicalAvslutadMild till måttlig akneFörenta staterna
-
Abramson Cancer Center of the University of PennsylvaniaIndragenAllvarlig eller mild toxicitet från strålbehandling och/eller kemoterapiFörenta staterna